Costs and Consequences Associated With Newer Medications for Glycemic Control in Type 2 Diabetes
Sinha, A., Rajan, M., Hoerger, T., & Pogach, L. (2010). Costs and Consequences Associated With Newer Medications for Glycemic Control in Type 2 Diabetes. Diabetes Care, 33(4), 695-700.
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Rate of onset of dopamine transporter inhibitors assessed with intracranial self-stimulation and in vivo dopamine photometry in rats
Personal exposure to PM2.5 in different microenvironments and activities for retired adults in two megacities, China
Estimating global artisanal fishing fleet responses in an era of rapid climate and economic change